Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Infection01:20

Infection

11.6K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
11.6K
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

524
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
524
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

676
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
676
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

2.5K
The pathophysiology of pneumonia involves the following steps:
2.5K
Stages of Infection01:26

Stages of Infection

64.7K
Stages of infection describe what happens to a susceptible host once a pathogen invades the human body. The stages of infection are incubation, prodromal, illness, stage of decline, and convalescence. The incubation stage is the period from exposure to a pathogen until symptoms start. The infected person is unaware of impending illness as the pathogens grow and multiply within the body. The duration may vary depending on the type of infection. The incubation period of measles averages ten to...
64.7K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

2.6K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
2.6K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Zebrafish as an Anti-Isogenic Vertebrate Model and What It Reveals About Genetic Background and Reproducibility.

BioEssays : news and reviews in molecular, cellular and developmental biology·2026
Same author

Subsidence more than doubles sea-level rise today along densely populated coasts.

Nature communications·2026
Same author

Critical role of Cas9 aggregation on in vitro DNA cleavage.

International journal of biological macromolecules·2026
Same author

Rethinking timing: Outcomes of late versus early surgical repair of complete atrioventricular septal defect in a resource-limited setting.

JTCVS open·2026
Same author

Targeting claudins in gastric cancer: A novel GLOWing strategy in the SPOTLIGHT.

Cancer treatment reviews·2026
Same author

Cyclopalladated Complexes With Functionalized Diphosphanes as Promising Antifungal Scaffolds.

Bioinorganic chemistry and applications·2026
Same journal

Breaking barriers: Enhancing access to dementia clinical trials in the United Kingdom-Insights from the Scientific Advisory Board of the Dame Barbara Windsor Dementia Goals Programme.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Estimated labor market outcomes of people progressing from preclinical to early-stage Alzheimer's disease in the United States.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Amyloid exacerbates tau and alpha-synuclein pathologies, behavioral impairments, and neuroinflammation in a mixed dementia model.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Ver todos los artículos relacionados
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: Jan 8, 2026

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses
09:07

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses

Published on: June 14, 2020

11.5K

Ciencia básica y patogénesis

Shrinath Kadamangudi1, Laura Sanchez1, Agenor Limon1

  • 1University of Texas Medical Branch, Galveston, TX, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
PubMed
Resumen
Este resumen es generado por máquina.

Este estudio revela que los oligómeros de tau tóxicos (tauO) en el tejido cerebral humano se dirigen preferentemente a las sinapsis presinápticas e inhibitorias. Estos hallazgos sugieren nuevas estrategias terapéuticas para las tauropatías centradas en mecanismos presinápticos.

Palabras clave:
oligómeros de tautauropatíassinapsis presinápticassinapsis inhibitoriasneurodegeneraciónvulnerabilidad sináptica

Más Videos Relacionados

A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia
13:45

A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia

Published on: September 21, 2019

6.0K
Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses
08:38

Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses

Published on: February 22, 2019

6.3K

Videos de Experimentos Relacionados

Last Updated: Jan 8, 2026

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses
09:07

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses

Published on: June 14, 2020

11.5K
A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia
13:45

A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia

Published on: September 21, 2019

6.0K
Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses
08:38

Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses

Published on: February 22, 2019

6.3K

Área de la Ciencia:

  • Neurociencia; Enfermedades neurodegenerativas; Plasticidad sináptica

Sus antecedentes:

  • La disfunción sináptica es una característica clave de las tauropatías, que impulsa el deterioro cognitivo.
  • Comprender la vulnerabilidad sináptica a la patología tau es crucial para desarrollar tratamientos eficaces.
  • Los mecanismos de vulnerabilidad sináptica en las tauropatías humanas no se comprenden bien.

Objetivo del estudio:

  • Investigar la vulnerabilidad de las sinapsis humanas a los oligómeros de tau solubles (tauO).
  • Determinar las poblaciones sinápticas específicas y los compartimentos celulares a los que se dirigen los tauO.
  • Identificar posibles dianas terapéuticas para las tauropatías mediante la comprensión de las interacciones tauO-sinapsis.

Principales métodos:

  • Se utilizó tejido cerebral post-mortem de casos de control y de tauropatía primaria relacionada con la edad (PART).
  • Se analizaron sinaptosomas mediante western blot, citometría de flujo y registros de pinza de dos electrodos.
  • Se aislaron y analizaron los interactomas de oligómeros de tau derivados del cerebro (BDTO) mediante LC-MS/MS.

Principales resultados:

  • Los oligómeros de tau (tauO) se unen preferentemente a las terminales presinápticas y a las vesículas sinápticas.
  • Las sinapsis GABAérgicas muestran una mayor afinidad por los tauO, que potencian las corrientes GABAérgicas.
  • Los agregados de tau elevados en el hipocampo de la PART se correlacionan con una disminución de la relación excitatoria/inhibitoria, lo que indica un cambio proinhibitorio.

Conclusiones:

  • Este estudio proporciona evidencia directa de la vulnerabilidad sináptica selectiva a los tauO en el tejido cerebral humano.
  • Los hallazgos resaltan una preferencia por las sinapsis presinápticas e inhibitorias, lo que desafía las terapias centradas en el postsinapsis.
  • La identificación del ciclo de las vesículas presinápticas como diana de los tauO requiere que las terapias contra la tau se adapten a poblaciones sinápticas específicas.